Artwork

Innhold levert av Bill Frist and A Second Opinion Podcast. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Bill Frist and A Second Opinion Podcast eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

126 - Paul Diaz, President & CEO of Myriad Genetics, on applying the power of data-driven genetic insights

41:49
 
Del
 

Arkivert serier ("Inaktiv feed" status)

When? This feed was archived on August 02, 2023 17:10 (9M ago). Last successful fetch was on June 27, 2023 13:36 (10M ago)

Why? Inaktiv feed status. Våre servere kunne ikke hente en gyldig podcast feed for en vedvarende periode.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 292681452 series 2667905
Innhold levert av Bill Frist and A Second Opinion Podcast. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Bill Frist and A Second Opinion Podcast eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Paul Diaz is President & CEO of Myriad Genetics. Thirty years ago, Myriad Genetics played a pivotal role in one of the most important breakthroughs in the history of healthcare: discovering the precise location and sequence of the BRCA1 and BRCA2 genes, which increase the risk of breast cancer. This led to the emergence of genetic testing as a tool that has saved millions of lives. Now, with Paul at the helm, Myriad Genetics aims to play as pivotal a role in the next 30 years of genetics and precision medicine as they did in the first 30, applying the power of data-driven genetic insights. You’ll want to hear how Paul and Myriad are empowering patients and physicians to better detect, treat, and prevent disease.

To learn more about the work Paul and Myriad Genetics are doing to lead the way on genetic testing and precision medicine, read Paul’s latest blog post: https://myriad.com/health-illuminated/

  continue reading

201 episoder

Artwork
iconDel
 

Arkivert serier ("Inaktiv feed" status)

When? This feed was archived on August 02, 2023 17:10 (9M ago). Last successful fetch was on June 27, 2023 13:36 (10M ago)

Why? Inaktiv feed status. Våre servere kunne ikke hente en gyldig podcast feed for en vedvarende periode.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 292681452 series 2667905
Innhold levert av Bill Frist and A Second Opinion Podcast. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Bill Frist and A Second Opinion Podcast eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Paul Diaz is President & CEO of Myriad Genetics. Thirty years ago, Myriad Genetics played a pivotal role in one of the most important breakthroughs in the history of healthcare: discovering the precise location and sequence of the BRCA1 and BRCA2 genes, which increase the risk of breast cancer. This led to the emergence of genetic testing as a tool that has saved millions of lives. Now, with Paul at the helm, Myriad Genetics aims to play as pivotal a role in the next 30 years of genetics and precision medicine as they did in the first 30, applying the power of data-driven genetic insights. You’ll want to hear how Paul and Myriad are empowering patients and physicians to better detect, treat, and prevent disease.

To learn more about the work Paul and Myriad Genetics are doing to lead the way on genetic testing and precision medicine, read Paul’s latest blog post: https://myriad.com/health-illuminated/

  continue reading

201 episoder

כל הפרקים

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett